Idorsia
Allschwil · Founded 2017
About Idorsia
The purpose of Idorsia is to discover, develop and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities and we want to transform the horizon of therapeutic options. In order to achieve this, we will develop Idorsia into a leading biopharmaceutical company, with a strong scientific core. Headquartered in Switzerland – a biotech-hub of Europe – Idorsia is a high-potential biopharmaceutical company, specialized in the discovery, development and commercialization of innovative small molecules, with the aim of transforming the horizon of therapeutic options.
Company Facts
- Founded: 2017
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $2.5B
- Funding stage: IPO
- Last round: Post-IPO Equity (Oct 2025)
- Ticker: six:IDIA
- Website: idorsia.com
- Phone: 41 58 844 00 00
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/idorsia-25538 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.